ACHV today

$6.78+$0.06 (+0.89%)close Nov 9, 2026

Trend

DailyDowntrend (confirmed)

4 hourLeaning Bullish

1 hourBullish

15 minSymmetric Triangle

5 minStrong Bullish

Daily trend turns up above $7.48

Key levels

Resistance$7.29

Resistance$6.83

Support$6.25

Support$5.76

About Achieve Life Sciences

Achieve Life Sciences is a clinical-stage pharmaceutical company developing cytisinicline, a plant-derived alkaloid, as a treatment for nicotine dependence. Its lead program targets smoking cessation, with a second program in development for quitting nicotine e-cigarettes. The company operates in the United States and holds rights to develop and commercialize cytisinicline outside parts of Europe and certain other regions.

Based on the company's 10-K filed Mar 24, 2026.

Nasdaq · Healthcare

ACHIEVE LIFE SCIENCES, INC. (ACHV)

$6.78+0.06 (+0.89%)

WATCHLISTGrade: BRisk: MEDIUM

1D 5D1M1Y 5Y MaxSign up for all timeframes

High6.91

Low6.52

Open6.83

Volume1.05M

Avg Vol1.32M

VWAP6.70

30d High8.09

30d Low6.38

30d Chg-11.83%

See full chart with real-time data

What Is the Price Target for ACHV?

SEPT Low Target

$12.00

SEPT Mid Target

$13.00

SEPT High Target

$18.00

Analyst Consensus

$13.00

Current: $6.71Upside: +93.7%Confidence: 65%Method: Analyst Consensus

Is ACHV a Buy or Sell Right Now?

Investability Score

WATCHLIST12-18 months

News summary · last 30 days

Nov 10▲ UpEarnings3 articles

Achieve Life Sciences reported its third-quarter fiscal 2026 results, posting a loss of $0.11 per share that was narrower than the $0.20 loss analysts expected. The company also disclosed $201.5 million in cash and equivalents at period end, alongside a Form 8-K filing covering a major company event. The better-than-expected earnings result is a bullish signal for the stock, though the 8-K and headline-only quarterly release carried neutral sentiment. Overall, the earnings beat points to a positive direction for ACHV shares.

Critical news

Nov 10HIGHEarnings: growth/beat

Thesis

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ACHV.

Start Free Trial →

Is ACHV Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

Analyst Consensus

Fair Value

$13.00

Moat Score

NONE

1/9

Piotroski Score

0.9

Altman Z-Score

What Is Smart Money Doing with ACHV?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

ACHV Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-0.81%

FCF Growth YoY

N/A%

Revenue Trend

UNKNOWN

Dark Pool Trades for ACHV

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for ACHV, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

Time	Price	Size	Value	Side
21:01:17	$6.78	1,830	$$12K	BUY
21:00:28	$6.78	6,886	$$47K	BUY
21:00:28	$6.78	2,689	$$18K	BUY
21:00:28	$6.78	5,083	$$34K	BUY
20:57:07	$6.78	2,000	$$14K	BUY

5 dark pool trades shown · $$125K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for ACHIEVE LIFE SCIENCES, INC. (ACHV) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

ACHV — frequently asked questions

What is ACHV stock price today?

ACHIEVE LIFE SCIENCES, INC. (ACHV) is at $6.78, up 0.89% (+$0.06) at the Nov 9, 2026 close.

Why is ACHV stock up today?

Nov 10, 2026: Achieve Life Sciences reported its third-quarter fiscal 2026 results, posting a loss of $0.11 per share that was narrower than the $0.20 loss analysts expected. The company also disclosed $201.5 million in cash and equivalents at period end, alongside a Form 8-K filing covering a major company event.

What is the ACHV price target?

The average analyst price target for ACHV is $13.00, ranging from $12 to $18, based on 4 analysts. Latest: Stifel initiates on Sep 30, 2026.

What do analysts rate ACHV?

Analyst ratings for ACHV: 0 Buy, 6 Hold, 0 Sell — consensus Hold.

Did ACHV beat earnings?

ACHV last reported on Nov 10, 2026: EPS -$0.11 vs -$0.20 expected — a beat of 45.0%.

Does ACHV pay a dividend?

ACHV does not currently pay a dividend.

What are ACHV support and resistance levels?

Support: $6.25, $5.76, $5.30. Resistance: $6.83, $7.29, $8.28.

What are insiders doing with ACHV?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on ACHV?

Nov 10, 2026: Achieve Life Sciences, Inc. filed a report on a major company event (Form 8-K) · Nov 10, 2026: AchieveRx Posts Results for Q3 of Fiscal 2026 · Nov 10, 2026: Achieve Life Sciences Posts Smaller Quarterly Loss Than Expected